Trial Profile
A multicenter, randomized, placebo-controlled, double-blind and crossover pilot trial with human alpha-1 antitrypsin in patients with chronic fatigue syndrome
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2018
Price :
$35
*
At a glance
- Drugs Alpha 1-antitrypsin (Primary)
- Indications Chronic fatigue syndrome
- Focus Therapeutic Use
- Sponsors Grifols
- 10 Jan 2018 Status changed from recruiting to discontinued.
- 21 Jul 2015 New trial record